SRZN Surrozen, Inc.

Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS).

$2.06
As of 09/30/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  08/09/2021
Outstanding shares:  35,122,863
Average volume:  11,288
Market cap:   $76,216,613
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.70
PS ratio:   0.00
Return on equity:   -74.63%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy